advanced-biotechnology-annual-pediatrics-2018-posters

Page 41

Volume 10

Journal of Archives of Medicine

Advanced Biotechnology & Annual Pediatrics 2018

November 28-29, 2018

Novel Trends and Advances in Biotechnology,

Cell & Stem Cell Research

Annual Congress on Pediatrics

World Congress on

November 28-29, 2018 Barcelona, Spain

Joint Event On

Use of an ionized salt nasal solution in asthmatics with high respiratory infection and its impact on

inspiratory and spiratory flow

Eduardo Antonio Lara-Pérez

, Felix Guillermo Márquez-Celedonio

and Cesar Virgen-Ortega

Director of Clinasma, Mexico

Director of Research in Medicine, Colombia

President college of pediatrics of tabasco, Mexico

Background:

Bronchial asthma is a condition that affects up to 13% of the school population, is associated with reduced

inspiratory and expiratory flows, rhinitis and respiratory infections. Ionic nasal saline solution is an adjuvant option for

treatment with bactericidal and virucidal effects.

Objective:

To determine the effect of the use of ionized nasal saline in the Maximum Inspiratory Flow (MIF) and pPeak

Expiratory Flow (PEF) and the frequency of respiratory infections in school children with bronchial asthma.

Material & Methods:

Pre-experimental study with baseline demographic, anthropometric measurements, frequency of

respiratory infections and inspiratory and expiratory flows. Follow-up for four months with monthly evaluations of mif, pef

and presence of respiratory infections. Inferential analysis with: chi square, mann-whitney, wilcoxon and student's t.

Results:

We included 80 schoolchildren of 8.7±2.1 years, height of 1.31±2.1 m, 48 (60.0%) of male and 32 female (40%). The

MIF evolved from 58.4±19.3 l/sec initial and 104.7±29.2 at four months (p<0.05), PEF initiation 192.7±58.7 to 222.3±67.0 final

(p<0.05) respiratory infections 100% to 88.8% first month and 0.0% at the end (p<0.05).

Conclusions:

The administration of ionized nasal saline solution in asthmatic school children allows to recover values of MIF

and PEF and to reduce the frequency of infectious airways, independently of the sex and category of acute or chronic infection.

Arch Med 2018, Volume 10

DOI: 10.21767/1989-5216-C2-006